Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-ULBP1 Antibody (R3Z36)

Catalog #:   RHK75201 Specific References (43) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM
Accession: Q9BZM6
Overview

Catalog No.

RHK75201

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400

Target

Retinoic acid early transcript 1I, UL16-binding protein 1, ALCAN-beta, N2DL-1, NKG2DL1, RAET1I, N2DL1, NKG2D ligand 1, ULBP1

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q9BZM6

Applications

ELISA, FCM

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3Z36

Data Image
  • Flow Cytometry
    Flow cytometric analysis of Hela cells using ULBP1 mouse mAb (green) and negative control (red).
References

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence., PMID:38741774

Dynamics of Soluble Forms of the Immune Checkpoint Components PD-1/PD-L1/B7-H3, CD314/ULBP1, and HLA-G in Peripheral Blood of Melanoma Patients Receiving Blockers of Programmed Cell Death Protein PD-1., PMID:37773572

Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients., PMID:36741391

The metabolism of cells regulates their sensitivity to NK cells depending on p53 status., PMID:35217717

The NKG2D ligand ULBP4 is not expressed by human monocytes., PMID:33556116

NK Cell Interaction With Platelets and Myeloid Cells in the Tumor Milieu., PMID:33424862

Production of a novel bispecific protein ULBP1×CD19-scFv targeting the NKG2D receptor and CD19 to promote the activation of NK cells., PMID:33122138

Human Metapneumovirus Escapes NK Cell Recognition through the Downregulation of Stress-Induced Ligands for NKG2D., PMID:32698530

UL16-Binding Protein 1 Induced HTR-8/SVneo Autophagy via NF-κB Suppression Mediated by TNF-α Secreted through uNK Cells., PMID:32626772

MICAgen Mice Recapitulate the Highly Restricted but Activation-Inducible Expression of the Paradigmatic Human NKG2D Ligand MICA., PMID:32582150

MG132 selectively upregulates MICB through the DNA damage response pathway in A549 cells., PMID:30483783

Xenogeneic transplantation and tolerance in the era of CRISPR-Cas9., PMID:30480643

Combined inhibition of JAK1,2/Stat3‑PD‑L1 signaling pathway suppresses the immune escape of castration‑resistant prostate cancer to NK cells in hypoxia., PMID:29693186

Cutting an NKG2D Ligand Short: Cellular Processing of the Peculiar Human NKG2D Ligand ULBP4., PMID:29651291

Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand., PMID:28203118

Immunohistochemical validation and expression profiling of NKG2D ligands in a wide spectrum of human epithelial neoplasms., PMID:25473094

Recognition of adult and pediatric acute lymphoblastic leukemia blasts by natural killer cells., PMID:24658822

Enhanced interaction between natural killer cells and lung cancer cells: involvement in gefitinib-mediated immunoregulation., PMID:23937717

Valproic acid upregulates NKG2D ligand expression and enhances susceptibility of human renal carcinoma cells to NK cell-mediated cytotoxicity., PMID:23671445

Valproic acid upregulates NKG2D ligand expression through an ERK-dependent mechanism and potentially enhances NK cell-mediated lysis of myeloma., PMID:23308050

Aberrantly decreased levels of NKG2D expression in children with kawasaki disease., PMID:23298273

Resveratrol sensitized leukemia stem cell-like KG-1a cells to cytokine-induced killer cells-mediated cytolysis through NKG2D ligands and TRAIL receptors., PMID:22406996

NKG2D ligand tumor expression and association with clinical outcome in early breast cancer patients: an observational study., PMID:22257486

Interleukin-10 promotes NK cell killing of autologous macrophages by stimulating expression of NKG2D ligands., PMID:20883317

Human IgG1 antibodies antagonizing activating receptor NKG2D on natural killer cells., PMID:20061825

NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes., PMID:19594748

Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCC., PMID:19358282

Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH., PMID:19013003

Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide., PMID:18463537

Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway., PMID:18441340

[Expression of NKG2D ligands on dendritic cells at different development stages and its effect on cytotoxicity of NK cells]., PMID:18394338

Induction of NKG2D ligands on human dendritic cells by TLR ligand stimulation and RNA virus infection., PMID:17878262

Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition., PMID:17635809

[Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells]., PMID:17584663

DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells., PMID:17283169

The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing., PMID:17079298

Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP., PMID:16195329

Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate., PMID:16024634

Consequences of human cytomegalovirus mimicry., PMID:15172446

Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors., PMID:15048706

Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity., PMID:12414645

UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells., PMID:11777960

ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells., PMID:11465099

Datasheet

Document Download

Anti-ULBP1 Antibody (R3Z36).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-ULBP1 Antibody (R3Z36) [RHK75201]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only